FDA
approval
· 2022-05-03
FDA Approved: LACOSAMIDE — Original Application (Fresenius Kabi USA, LLC)
Summary
The FDA approved Fresenius Kabi USA, LLC's original application for lacosamide (ANDA214677), allowing the marketing of a generic lacosamide product.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for LACOSAMIDE (LACOSAMIDE)